Skip to main content
. 2022 Feb 3;11:e71846. doi: 10.7554/eLife.71846

Appendix 2—table 1. Post-hoc analyses of age and sex.

Original analysis Original analysis +age and sex Age and sex only
X 2 p-Value X2 p-Value X 2 p-Value
Putamen
Patients vs. controlsRight tremor-dominant Parkinson’s disease 27.17 0.007 27.21 0.018 0.48 0.786
UPDRS symptom severityRight tremor-dominant Parkinson’s disease 22.28 0.035 23.46 0.053 2.38 0.305
L-DOPA-placebo differenceLeft tremor-dominant Parkinson’s disease 34.07 0.001 46.14 <0.001 2.42 0.299
L-DOPA-placebo differenceRight tremor-dominant Parkinson’s disease 25.48 0.012 37.53 0.001 7.18 0.028
Caudate-NAcc
Tobacco useHCP dataset 49.55 0.002 53.56 0.001 1.04 0.594
Alcohol useHCP dataset 64.45 <0.001 174.87 <0.001 9.26 0.010

UPDRS = Unified Parkinson’s Disease Rating Scale; L-DOPA = levodopa-benserazide; HCP = Human Connectome Project; NAcc = nucleus accumbens.